Geneesmiddelenbeleid

This procedure is a motion from the Dutch House of Representatives regarding the national policy on pharmaceuticals. It aims to address the strategic management of medicines to ensure healthcare quality and accessibility. This will primarily affect the healthcare sector, pharmaceutical providers, and patients by potentially altering how medicines are procured, priced, or distributed within the Netherlands.